Skip to Main Content

Author Details

Adam J Krieg
Oregon Health and Sciences University
1999
30
23
PMIDPaper TitleJournal TitlePublished Year
34262028The HIF target MAFF promotes tumor invasion and metastasis through IL11 and STAT3 signaling.Nat Commun2021
34766154Histone lysine demethylase 4B regulates general and unique gene expression signatures in hypoxic cancer cells.MedComm (2020)2021
32165999Subcellular localization of FANCD2 is associated with survival in ovarian carcinoma.Oncotarget2020
30759871KDM4B: A Nail for Every Hammer?Genes (Basel)2019
30862717Collagen Remodeling in the Hypoxic Tumor-Mesothelial Niche Promotes Ovarian Cancer Metastasis.Cancer Res2019
30886884The dilemma of early preventive oophorectomy in familial small cell carcinoma of the ovary of hypercalcemic type.Gynecol Oncol Rep2019
29536385Histone demethylase KDM4A and KDM4B expression in granulosa cells from women undergoing in vitro fertilization.J Assist Reprod Genet2018
29891506Licofelone Enhances the Efficacy of Paclitaxel in Ovarian Cancer by Reversing Drug Resistance and Tumor Stem-like Properties.Cancer Res2018
28073943KDM4B/JMJD2B is a p53 target gene that modulates the amplitude of p53 response after DNA damage.Nucleic Acids Res2017
28320353Genome-independent hypoxic repression of estrogen receptor alpha in breast cancer cells.BMC Cancer2017
28894274KDM4A regulates HIF-1 levels through H3K9me3.Sci Rep2017
27869162The histone demethylase KDM4B regulates peritoneal seeding of ovarian cancer.Oncogene2017
27807143HIF-KDM3A-MMP12 regulatory circuit ensures trophoblast plasticity and placental adaptations to hypoxia.Proc Natl Acad Sci U S A2016
25792458Hypoxic induction of AKAP12 variant 2 shifts PKA-mediated protein phosphorylation to enhance migration and metastasis of melanoma cells.Proc Natl Acad Sci U S A2015
26426056Epigenetic Therapy for Solid Tumors: Highlighting the Impact of Tumor Hypoxia.Genes (Basel)2015
25187556Direct regulation of GAS6/AXL signaling by HIF promotes renal metastasis through SRC and MET.Proc Natl Acad Sci U S A2014
24037093Cross-talk between hypoxia and insulin signaling through Phd3 regulates hepatic glucose and lipid metabolism and ameliorates diabetes.Nat Med2013
22505054Global alteration in gene expression profiles of deciduas from women with idiopathic recurrent pregnancy loss.Mol Hum Reprod2012
21233420VHL loss in renal cell carcinoma leads to up-regulation of CUB domain-containing protein 1 to stimulate PKC{delta}-driven migration.Proc Natl Acad Sci U S A2011
19858293Regulation of the histone demethylase JMJD1A by hypoxia-inducible factor 1 alpha enhances hypoxic gene expression and tumor growth.Mol Cell Biol2010
20858715AXL is an essential factor and therapeutic target for metastatic ovarian cancer.Cancer Res2010
18471976The metastasis-associated gene Prl-3 is a p53 target involved in cell-cycle regulation.Mol Cell2008
17575159Targeting the loss of the von Hippel-Lindau tumor suppressor gene in renal cell carcinoma cells.Cancer Res2007
17998061HIF gene expression in cancer therapy.Methods Enzymol2007
16611991Genome-wide analysis of p53 under hypoxic conditions.Mol Cell Biol2006
16760660Checking in on hypoxia/reoxygenation.Cell Cycle2006
16980608Functional analysis of p53 binding under differential stresses.Mol Cell Biol2006
14617632Interplay between estrogen response element sequence and ligands controls in vivo binding of estrogen receptor to regulated genes.J Biol Chem2004
11682627A unique downstream estrogen responsive unit mediates estrogen induction of proteinase inhibitor-9, a cellular inhibitor of IL-1beta- converting enzyme (caspase 1).Mol Endocrinol2001
10372358Interactions of high mobility group box proteins with DNA and chromatin.Methods Enzymol1999
  • 1 - 30 of 30

Recommended Authors

the Second Hospital, Cheeloo College of Medicine, Shandong University
Career Start Year 2011
Number of shared co-authors 0
McDermott Center for Human Growth and Development.
Career Start Year 2010
Number of shared co-authors 1
Stanford University School of Medicine
Career Start Year 2007
Number of shared co-authors 0
University of Helsinki
Career Start Year 2006
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 0
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 0
Biomedicine Discovery Institute, Monash University
Career Start Year 2005
Number of shared co-authors 0
Maastricht University Medical Center
Career Start Year 2005
Number of shared co-authors 0
University of Nebraska Medical Center
Career Start Year 2005
Number of shared co-authors 0
International Centre for Genetic Engineering and Biotechnology
Career Start Year 2004
Number of shared co-authors 0
QIMR Berghofer Medical Research Institute
Career Start Year 2003
Number of shared co-authors 3
The University of Hong Kong
Career Start Year 2003
Number of shared co-authors 0
The Wistar Institute
Career Start Year 2003
Number of shared co-authors 0
National Cancer Institute, National Institutes of Health
Career Start Year 2002
Number of shared co-authors 0
Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Career Start Year 2001
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2001
Number of shared co-authors 0
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year 2001
Number of shared co-authors 1
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Career Start Year 1999
Number of shared co-authors 0
Roswell Park Comprehensive Cancer Center
Career Start Year 1999
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 0
University of Texas Health San Antonio (UTHSA)
Career Start Year 1997
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 1997
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 0
Indiana University School of Medicine
Career Start Year 1993
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 0
The Institute of Cancer Research
Career Start Year 1988
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1987
Number of shared co-authors 0
Rutgers New Jersey Medical School
Career Start Year 1987
Number of shared co-authors 0
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Career Start Year 1987
Number of shared co-authors 0
Peter MacCallum Cancer Centre
Career Start Year 1983
Number of shared co-authors 3

Collaborators

London Health Sciences Centre Parkwood Institute (EF)
Co-authored papers 4
Co-authored papers 3
University of Kansas Medical Center
Co-authored papers 2
Oregon Health & Science University
Co-authored papers 2
Oregon Health & Science University
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Oregon Health & Science University
Co-authored papers 1
Oregon Health & Science University
Co-authored papers 1
Co-authored papers 1
Saint Louis University
Co-authored papers 1
Oregon Health & Science University, University of California Berkeley
Co-authored papers 1
University of Kansas
Co-authored papers 1
Knight Cancer Institute, Oregon Health and Science University
Co-authored papers 1
Segal Cancer Centre, Jewish General Hospital
Co-authored papers 1
University of Southern California
Co-authored papers 1